.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
Federal Trade Commission
Accenture
Healthtrust
Cerilliant
Fish and Richardson

Generated: July 23, 2017

DrugPatentWatch Database Preview

FENTANYL-12 Drug Profile

« Back to Dashboard

What is the patent landscape for Fentanyl-12, and what generic Fentanyl-12 alternatives are available?

Fentanyl-12 is a drug marketed by Aveva, Mallinckrodt Inc, Mylan Technologies, and 3m Drug Delivery. and is included in four NDAs.

The generic ingredient in FENTANYL-12 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fentanyl profile page.

Summary for Tradename: FENTANYL-12

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list11
Bulk Api Vendors: see list20
Clinical Trials: see list813
Patent Applications: see list6,600
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FENTANYL-12 at DailyMed

Pharmacology for Tradename: FENTANYL-12

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aveva
FENTANYL-12
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077449-005Sep 11, 2015ABRXNoNo► Subscribe► Subscribe
3m Drug Delivery
FENTANYL-12
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL202097-001Nov 4, 2016ABRXNoNo► Subscribe► Subscribe
Mallinckrodt Inc
FENTANYL-12
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL077154-005Jun 11, 2015ABRXNoNo► Subscribe► Subscribe
Mylan Technologies
FENTANYL-12
fentanyl
FILM, EXTENDED RELEASE;TRANSDERMAL076258-005Jan 23, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Novartis
Cipla
Farmers Insurance
Merck
Citi
Johnson and Johnson
Fuji
McKinsey
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot